Sensus Healthcare, Inc. Units Separate; Trading of Common Stock and Warrants Commences

Sensus Healthcare, Inc. Units Separate; Trading of Common Stock and Warrants Commences

Sensus Healthcare, Inc. , a medical device company specializing in the treatment of non-melanoma skin cancers and other skin conditions, such as keloids, with superficial radiation therapy, today reported the separation of the 2,300,000 units issued in its underwritten initial public offering in accordance with their terms. Each unit will separate into one share of common stock, $0.01 par value per share, and a three-year warrant to purchase one share of common stock at an initial exercise price of $6.75 per share.

from Biotech News